Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tracon Pharmaceuticals Inc
(NQ:
TCON
)
1.430
-0.100 (-6.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tracon Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 16, 2022
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 16, 2022
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million....
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study
March 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
March 16, 2022
Gainers Fangdd Network Group Ltd. (NASDAQ: DUO) rose 57.1% to $0.4198 in pre-market trading. KE Holdings Inc. (NYSE: BEKE) shares rose 38.5% to $12.57 in pre-market trading. JP...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 16, 2022
Rise and shine, investor! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday.
Via
InvestorPlace
TRACON Pharmaceuticals: Q4 Earnings Insights
March 15, 2022
TRACON Pharmaceuticals (NASDAQ:TCON) reported its Q4 earnings results on Tuesday, March 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For March 15, 2022
March 15, 2022
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...
Via
Benzinga
Preview: TRACON Pharmaceuticals's Earnings
March 14, 2022
TRACON Pharmaceuticals (NASDAQ:TCON) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement....
Via
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
4 Penny Stocks Insiders Are Buying: Ideanomics, Superior Industries And More
January 24, 2022
The IHS Markit composite PMI dipped to 50.8 in January 2022 from 57.0 a month ago, according to data released today. However, investors also focuse...
Via
Benzinga
78 Biggest Movers From Yesterday
March 11, 2022
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (...
Via
Benzinga
5 Penny Stocks Insiders Are Buying
December 30, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 29, 2021
Gainers Cognition Therapeutics (NASDAQ:CGTX
Via
Benzinga
51 Biggest Movers From Yesterday
December 28, 2021
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to...
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike Higher
December 27, 2021
Toward the end of trading Monday, the Dow traded up 0.64% to 36,181.37 while the NASDAQ rose 1.19% to 15,838.88. The S&P also rose, gaining 1.07% to 4,776.31. The U.S. has the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 27, 2021
Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 47.87% to $8.02 during Monday's regular session. The current volume of 63.6 million shares is 153229.83%...
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
December 27, 2021
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY...
Via
Benzinga
54 Biggest Movers From Thursday
December 27, 2021
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 20, 2021
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD
Via
Benzinga
5 Penny Stocks Insiders Are Buying
December 08, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 02, 2021
Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million...
Via
Benzinga
Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xenco In $480 Million Deal
November 27, 2021
In a $480 million deal, Zenas acquired global rights to a bifunctional antibody from Xencor that targets CD19. Instead of an upfront payment, Zenas will issue a warrant granting Xencor the right to...
Via
Talk Markets
5 Stocks Insiders Are Still Buying (Even As Others Cash Out)
November 12, 2021
Insider sales are generally a sign the market is about to drop, but not everyone's selling. Here are five companies with insider buying.
Via
InvestorPlace
Earnings Scheduled For November 3, 2021
November 03, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....
Via
Benzinga
Week In Review: Hansoh Signs $456 Million Deal For siRNA Products
October 16, 2021
Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to...
Via
Talk Markets
TRACON Pharma, Eucure Join Forces To Develop CTLA-4 Antibody For Oncology Indications
October 11, 2021
TRACON Pharmaceuticals Inc (NASDAQ: TCON) entered into a collaborative partnership agreement with Eucure Biopharma, a subsidiary of Biocytogen Pharmaceuticals (...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 11, 2021
Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at...
Via
Benzinga
TRACON Pharmaceuticals on the Fast Track for Sarcoma Injection Treatments
September 07, 2021
Sarcoma is not one of the many cancers that reaches top billing in the discussion of cancer research. The cancer starts in tissues like bone, muscle or soft tissue and...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.